The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity

Modulation of DNA damage response and induction of apoptosis mediates synergism between doxorubicin and a new imidazopyridine derivative in breast and lung cancer cells

(2016) Raafat A. El-Awady et al.   DNA REPAIR

Testosterone Antagonizes Doxorubicin‐Induced Senescence of Cardiomyocytes

(2016) Paola Altieri et al.   Journal of the American Heart Association

Akt—mTOR Pathway Inhibits Apoptosis and Fibrosis in Doxorubicin-Induced Cardiotoxicity following Embryonic Stem Cell Transplantation

(2015) Dinender K. Singla   CELL TRANSPLANTATION

Embryonic Stem Cells and Released Factors Stimulate c-kit+/FLK-1+ Progenitor Cells and Promote Neovascularization in Doxorubicin-Induced Cardiomyopathy

(2015) Dinender K. Singla et al.   CELL TRANSPLANTATION

Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy

(2015) D. Cardinale et al.   CIRCULATION

Noninvasive Molecular Imaging of Apoptosis in a Mouse Model of Anthracycline-Induced Cardiotoxicity

(2015) H. Su et al.   Circulation-Cardiovascular Imaging

Doxorubicin Impairs the Insulin-Like Growth Factor-1 System and Causes Insulin-Like Growth Factor-1 Resistance in Cardiomyocytes

(2015) Patrizia Fabbi et al.   PLoS One

Potent Paracrine Effects of human induced Pluripotent Stem Cell-derived Mesenchymal Stem Cells Attenuate Doxorubicin-induced Cardiomyopathy

(2015) Yuelin Zhang et al.   Scientific Reports

Endothelial properties of third-trimester amniotic fluid stem cells cultured in hypoxia

(2015) Andrea Alex Schiavo et al.   Stem Cell Research & Therapy

Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs

(2015) Marilisa Molinaro et al.   Biomed Research International

Therapeutic Administration of the Chemokine CXCL1/KC Abrogates Autoimmune Inflammatory Heart Disease

(2014) Kurt Bachmaier et al.   PLoS One

Notch-1 Mediated Cardiac Protection following Embryonic and Induced Pluripotent Stem Cell Transplantation in Doxorubicin-Induced Heart Failure

(2014) Hilda Merino et al.   PLoS One

An Integrated Characterization of Serological, Pathological, and Functional Events in Doxorubicin-Induced Cardiotoxicity

(2014) Laura Cove-Smith et al.   TOXICOLOGICAL SCIENCES

Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies

(2014) Virginia Shalkey Hahn et al.   Journal of the American Heart Association

Doxorubicin induces senescence and impairs function of human cardiac progenitor cells

(2013) Elena Piegari et al.   BASIC RESEARCH IN CARDIOLOGY

Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool

(2013) Edward Y Chen et al.   BMC BIOINFORMATICS

FGF-2 protects cardiomyocytes from doxorubicin damage via protein kinase C-dependent effects on efflux transporters

(2013) Jie Wang et al.   CARDIOVASCULAR RESEARCH

Amniotic fluid stem cells improve survival and enhance repair of damaged intestine in necrotising enterocolitis via a COX-2 dependent mechanism

(2013) Augusto Zani et al.   GUT

Treatment-related cardiotoxicity in survivors of childhood cancer

(2013) Steven E. Lipshultz et al.   Nature Reviews Clinical Oncology

Embryonic Stem Cells Improve Cardiac Function in Doxorubicin-Induced Cardiomyopathy Mediated through Multiple Mechanisms

(2012) Dinender K. Singla et al.   CELL TRANSPLANTATION

p42/p44-MAPK and PI3K are sufficient for IL-6 family cytokines/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK/STAT activation

(2012) Ahmed Fahmi et al.   CELLULAR SIGNALLING

Cancer drugs and the heart: importance and management

(2012) T. M. Suter et al.   EUROPEAN HEART JOURNAL

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

(2012) Yanti Octavia et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Identification of the molecular basis of doxorubicin-induced cardiotoxicity

(2012) Sui Zhang et al.   NATURE MEDICINE

Heat shock factor-1 knockout induces multidrug resistance gene, MDR1b, and enhances P-glycoprotein (ABCB1)-based drug extrusion in the heart

(2012) K. Krishnamurthy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model

(2011) Teodelinda Mirabella et al.   BIOMATERIALS

Amniotic Fluid Stem Cells Are Cardioprotective Following Acute Myocardial Infarction

(2011) Sveva Bollini et al.   STEM CELLS AND DEVELOPMENT

C-kit+ cardiac progenitors exhibit mesenchymal markers and preferential cardiovascular commitment

(2010) Elisa Gambini et al.   CARDIOVASCULAR RESEARCH

Juvenile Exposure to Anthracyclines Impairs Cardiac Progenitor Cell Function and Vascularization Resulting in Greater Susceptibility to Stress-Induced Myocardial Injury in Adult Mice

(2010) Chengqun Huang et al.   CIRCULATION

PHLPP-1 Negatively Regulates Akt Activity and Survival in the Heart

(2010) Shigeki Miyamoto et al.   CIRCULATION RESEARCH

Paracrine mechanisms of stem cell reparative and regenerative actions in the heart

(2010) Maria Mirotsou et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Anthracycline Cardiomyopathy Is Mediated by Depletion of the Cardiac Stem Cell Pool and Is Rescued by Restoration of Progenitor Cell Function

(2009) Antonella De Angelis et al.   CIRCULATION

Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy

(2008) Massimiliano Gnecchi et al.   CIRCULATION RESEARCH